Anthropic’s confirmation of a physical wet lab in the San Francisco Bay Area has sharpened trader focus on any potential lab leak market. Reported September 18, the facility supports real-world biology experiments alongside Claude-directed automation, building on the company’s June Claude Science program and recent Life Sciences Verification Program launch. This shift from simulation-only work occurs as Anthropic’s September threat report detailed blocked attempts to misuse its models for pathogen research, including gain-of-function studies on avian influenza and chikungunya. Traders are weighing the lab’s undisclosed biosafety protocols and early-stage robot integration against the company’s emphasis on human oversight and external partnerships. Key near-term catalysts include further details on experiment scope or regulatory scrutiny that could alter perceived incident risk.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · ActualizadoNUEVO
$21,294 Vol.
31 dic 2026
31 de diciembre de 2026
4%
30 de junio de 2027
11%
$21,294 Vol.
31 de diciembre de 2026
$14,632 Vol.
4%
30 de junio de 2027
$6,662 Vol.
11%
This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.Anthropic’s confirmation of a physical wet lab in the San Francisco Bay Area has sharpened trader focus on any potential lab leak market. Reported September 18, the facility supports real-world biology experiments alongside Claude-directed automation, building on the company’s June Claude Science program and recent Life Sciences Verification Program launch. This shift from simulation-only work occurs as Anthropic’s September threat report detailed blocked attempts to misuse its models for pathogen research, including gain-of-function studies on avian influenza and chikungunya. Traders are weighing the lab’s undisclosed biosafety protocols and early-stage robot integration against the company’s emphasis on human oversight and external partnerships. Key near-term catalysts include further details on experiment scope or regulatory scrutiny that could alter perceived incident risk.
This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
Mercado abierto: Sep 18, 2026, 8:27 PM ET
Volumen
$21,294Fecha de finalización
1 jul 2027Mercado abierto
Sep 18, 2026, 8:27 PM ETResolver
0x65070BE91...This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.Anthropic’s confirmation of a physical wet lab in the San Francisco Bay Area has sharpened trader focus on any potential lab leak market. Reported September 18, the facility supports real-world biology experiments alongside Claude-directed automation, building on the company’s June Claude Science program and recent Life Sciences Verification Program launch. This shift from simulation-only work occurs as Anthropic’s September threat report detailed blocked attempts to misuse its models for pathogen research, including gain-of-function studies on avian influenza and chikungunya. Traders are weighing the lab’s undisclosed biosafety protocols and early-stage robot integration against the company’s emphasis on human oversight and external partnerships. Key near-term catalysts include further details on experiment scope or regulatory scrutiny that could alter perceived incident risk.
This market will resolve to “Yes” if a pathogen developed, modified, or handled at a wet lab operated by Anthropic is confirmed to have escaped that facility between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to “No.”
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
Confirmation that the pathogen escaped the laboratory, research facility, diagnostic facility, or other controlled laboratory setting in which it was contained is required.
Investigations, speculation, statements that an escape is possible or has not been ruled out, or statements unverified by a consensus of credible reporting will not suffice.
The primary resolution source for this market will be a consensus of credible reporting.
Volumen
$21,294Fecha de finalización
1 jul 2027Mercado abierto
Sep 18, 2026, 8:27 PM ETResolver
0x65070BE91...Anthropic’s confirmation of a physical wet lab in the San Francisco Bay Area has sharpened trader focus on any potential lab leak market. Reported September 18, the facility supports real-world biology experiments alongside Claude-directed automation, building on the company’s June Claude Science program and recent Life Sciences Verification Program launch. This shift from simulation-only work occurs as Anthropic’s September threat report detailed blocked attempts to misuse its models for pathogen research, including gain-of-function studies on avian influenza and chikungunya. Traders are weighing the lab’s undisclosed biosafety protocols and early-stage robot integration against the company’s emphasis on human oversight and external partnerships. Key near-term catalysts include further details on experiment scope or regulatory scrutiny that could alter perceived incident risk.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado
Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes